SMAD2 and hepatocellular carcinoma: In a loss of function study, FXR1 knockdown reduces hepatocellular carcinoma (HCC) cell invasion and migration via TGF-β modulation, whereas upregulation in HCC cells increases cell invasion which is abrogated by inhibiting SMAD2/3.